Watson Said to Be in Talks to Buy Swiss Drugmaker Actavis

Watson Pharmaceuticals Inc. is nearing an agreement to purchase Swiss drugmaker Actavis Group hf, creating one of the world’s largest producers of generic drugs, according to people familiar with the process.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.